Axsome Therapeutics (AXSM) Asset Utilization Ratio (2022 - 2026)
Axsome Therapeutics recorded quarterly Asset Utilization Ratio of 1.01 in Q1 2026, up 7.42% quarter-over-quarter from 0.94 in Q4 2025, and up 87.33% year-over-year from 0.54 in Q1 2025.
Axsome Therapeutics' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 1.01 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 87.33% year-over-year to 1.01; the TTM figure through Mar 2026 stood at 1.01 (up 87.33% YoY), while the FY2025 annual figure was 1.01, up 52.18% from the prior year.
- Asset Utilization Ratio came in at 1.01 for Q1 2026 at Axsome Therapeutics, up from 0.94 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.01 in Q1 2026 to a low of 0.1 in Q3 2022.
- A 5-year average of 0.51 and a median of 0.47 in 2024 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio soared 273.01% in 2023 and rose 4.0% in 2024, its largest moves.
- Axsome Therapeutics' Asset Utilization Ratio stood at 0.15 in 2022, then soared by 204.91% to 0.46 in 2023, then gained by 4.0% to 0.47 in 2024, then jumped by 98.51% to 0.94 in 2025, then rose by 7.42% to 1.01 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.01, 0.94, and 0.68 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | 1.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 |
| Dec 31, 2025 | 0.94 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.61 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | 0.61 |
| Jun 30, 2024 | 0.53 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 0.37 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.40 |
| Dec 31, 2022 | 0.15 |
| Sep 30, 2022 | 0.10 |